Close Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

F-Prime Capital

Investor type Venture Capital

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 382
Average round size
info
The average size of a deal this fund participated in
$38M
Portfolio companies 222
Rounds per year 5.03
Lead investments 15
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.42
Exits 63
Key employees 11
Stages of investment
Early Stage Venture
Late Stage Venture
Seed

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Software

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of F-Prime Capital:
Typical Co-investors
F-Prime Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after F-Prime Capital:

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

RIGImmune

Biopharma
Pharmaceutical
15 Sep 2022 Farmington, Connecticut, United States

Hone

Corporate Training
Education
Fitness
Internet
SaaS
Software
Sports
$30M13 Sep 2022 San Francisco, California, United States

Latchel

Building Maintenance
Property Management
Real Estate
Rental Property
$16M27 Jul 2022 Seattle, Washington, United States

Spry

Fitness
Health Care
Wellness
$7M22 Jun 2022 New Jersey, Maryland, United States

Immuneel Therapeutics

Biotechnology
Health Care
Product Research
$15M21 Jun 2022 Bengaluru, Karnataka, India

Vendr

Information Technology
SaaS
Software
$150M16 Jun 2022 Boston, Massachusetts, United States

Proximie

Augmented Reality
Collaboration
Health Care
Medical
$80M14 Jun 2022 London, England, United Kingdom

Peptone

Artificial Intelligence
Biotechnology
Pharmaceutical
Quantum Computing
$40M09 Jun 2022 London, England, United Kingdom

Teleo

Construction
Fleet Management
Robotics
$12M08 Jun 2022 Palo Alto, California, United States
News
ShouTi Secures $100 Million Series B Financing to Accelerate Development of Life-Changing Medicines Fueled by Advanced Computational, Structure-Based Drug Design Platform

– ShouTi Inc. announced the close of a $100m Series B financing round.
– The round was led by BVF Partners. Additional new investors include Casdin Capital, Cormorant Asset Management, Janus Henderson Investors, Lilly Asia Ventures, Monashee Capital, Sage Partners, Stork Capital, Surveyor Capital (a Citadel company), TCG X, Terra Magnum Capital Partners, Woodline Partners, and co-founder and strategic partner Schrödinger.
– Existing investors also participated in the financing, including Eight Roads, F-Prime Capital Partners, Qiming Venture Partners, Sequoia Capital China, TF Capital and Wuxi AppTec.

Centivo raises $51 million as more employers seek affordable, quality healthcare for their employees

– Centivo, a new health plan for self-funded employers that is anchored around leading providers of value-based care, announced today that it has raised an additional $51 million in funding.
B Capital Group, a leading global technology investor, and Maverick co-led the round.
– Additional existing investors, including Bain Capital Ventures, Company Ventures, Define Ventures, F-Prime Capital, HarbourVest Partners, Ingleside Investors, Nassau Street Ventures, an AVG fund and various individuals also participated.
– These funds will support Centivo’s rapid growth and expansion amid increased demand from employers for health plans that are structurally built to address employee healthcare affordability.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent F-Prime Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: